Unilife Corp (UNIS) 4.32 $UNIS
Unilife's (UNIS) CEO Alan Shortall on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Feb 09, 7:58PM CST
UNIS: 4.32 (+0.06)
Unilife reports 2Q loss
Automated Insights - Mon Feb 09, 5:01PM CST
YORK, Pa. (AP) _ Unilife Corp. (UNIS) on Monday reported a loss of $19.4 million in its fiscal second quarter.
UNIS: 4.32 (+0.06)
Unilife (UNIS) Q2 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Feb 09, 3:25PM CST
UNIS: 4.32 (+0.06)
Unilife Corporation beats by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 3:13PM CST
UNIS: 4.32 (+0.06)
Unilife Corporation Announces Financial Results For Fiscal Year 2015 Second Quarter
PR Newswire - Mon Feb 09, 3:05PM CST
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended December 31, 2014 ("the second quarter of Fiscal Year 2015", "2Q FY15" or "Current Quarter" .
UNIS: 4.32 (+0.06)
Unilife to Participate in the 2015 Leerink Global Healthcare Conference
PR Newswire - Fri Feb 06, 9:08AM CST
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS, ASX: UNS), today announced that its Chairman and CEO, Alan Shortall will participate in a fireside chat at the Leerink Global Healthcare Conference at 1:50 p.m. EST on Thursday, February 12, 2015. The conference will be held at The Waldorf Astoria Hotel in New York City, New York.
UNIS: 4.32 (+0.06)
Unilife Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares
PR Newswire - Wed Feb 04, 8:25AM CST
Unilife Corporation ("Unilife" (NASDAQ: UNIS, ASX: UNS), a leading developer and supplier of injectable drug delivery systems, today announced the closing of its previously announced public offering in the United States of common stock. Prior to the closing, the underwriters exercised in full their option to purchase an additional 1,650,000 shares of common stock. As a result, Unilife issued a total of 12,650,000 shares in the offering at a public price of $3.75 per share.
UNIS: 4.32 (+0.06)
Unilife Corporation To Announce Financial Results For Second Quarter Fiscal 2015 On Monday, February 9, 2015
PR Newswire - Mon Feb 02, 7:00AM CST
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the second quarter fiscal 2015 ended December 31, 2014 after market trading ends on Monday, February 9, 2015.
UNIS: 4.32 (+0.06)
Unilife (UNIS) Stock Lower Today After Pricing Public Offering
at The Street - Fri Jan 30, 9:51AM CST
Shares of Unilife (UNIS) are down today on heavy trading volume after the company announced a public offering of stock at a price of $3.75 per share.
UNIS: 4.32 (+0.06)
Unilife initiates equity offering
Seeking Alpha - at Seeking Alpha - Fri Jan 30, 9:04AM CST
UNIS: 4.32 (+0.06)
Unilife Corporation Prices Underwritten Offering of Common Stock
PR Newswire - Fri Jan 30, 8:25AM CST
Unilife Corporation ("Unilife" (NASDAQ: UNIS, ASX: UNS), a leading developer and supplier of injectable drug delivery systems, today announced the pricing of an underwritten public offering in the United States of 11,000,000 shares of its common stock to the public at a price of $3.75 per share. The net proceeds from the offering to Unilife are expected to be $38,792,500, after deducting underwriting discounts and commissions and estimated offering expenses payable by Unilife. In addition, Unilife has granted the underwriters an option for a period of 30 days to purchase up to an additional 1,650,000 shares of its common stock. The offering is expected to close on February 4, 2015, subject to customary closing conditions.
UNIS: 4.32 (+0.06)
Unilife Corporation Announces Public Offering of Common Stock
PR Newswire - Thu Jan 29, 6:20PM CST
Unilife Corporation ("Unilife" (NASDAQ: UNIS, ASX: UNS), a leading developer and supplier of injectable drug delivery systems, today announced it intends to offer and sell, subject to market conditions, shares of its common stock (which will be issued in the form of CHESS Depositary Interests to Australian investors) in an underwritten public offering in the United States and a private placement in Australia (together the "Offering" . Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the proposed Offering. Unilife expects to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the shares of common stock sold in the Offering. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the final size or terms (including price) of the Offering.
UNIS: 4.32 (+0.06)
Unilife: Ready For Phase 2 Of A Huge Move
RightEdge Analytics - Seeking Alpha - Thu Jan 29, 10:44AM CST
Update: This article is to update on the recent announcements and runup in share price since the first article that we published on Unilife (NASDAQ: UNIS ) on September 19, 2014 . Since this article UNIS has increased in value by about 70%. This is...
UNIS: 4.32 (+0.06), JPM: 59.67 (+0.10), INCY: 75.94 (+0.28), ABBV: 58.05 (+1.00), SNY: 49.42 (+0.82)
Can the Uptrend Continue for Unilife (UNIS)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 7:37AM CST
Can the Uptrend Continue for Unilife (UNIS)?
UNIS: 4.32 (+0.06)
Health Care Supplies Stocks Technical Review - Cerus, Unilife, DENTSPLY Intl., Alere, and Align Technology
PR Newswire - Thu Jan 22, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Cerus Corporation (NASDAQ: CERS), Unilife Corporation (NASDAQ: UNIS), DENTSPLY International Inc. (NASDAQ: XRAY), Alere Inc. (NYSE: ALR), and Align Technology Inc. (NASDAQ: ALGN). Free research report on Cerus can be accessed at http://get.Investor-Edge.com/pdf/?c=Cerus&...amp;s=CERS. On Wednesday, January 21, 2015, the NASDAQ Composite ended at 4,667.42, up 0.27%, the Dow Jones Industrial Average advanced 0.22%, to finish the day at 17,554.28, and the S&P 500 closed at 2,032.12, up 0.47%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 814.90, up 0.11%, with the index also advancing 10.82% in the previous three months. Register for your complimentary reports at the links given below.
CERS: 5.53 (+0.08), ALGN: 56.90 (-0.34), UNIS: 4.32 (+0.06), ALR: 43.40 (-0.40), XRAY: 52.74 (+0.32)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 8:16AM CST
BCS: 15.77 (+0.12), ANV: 0.97 (-0.03), FRO: 2.96 (+0.07), BAK: 9.02 (+0.03), UNIS: 4.32 (+0.06), EXPR: 14.61 (+0.33), ASPS: 22.32 (+0.09), ISR: 1.34 (-0.06), AU: 12.33 (+0.36), MHR: 2.62 (+0.11), SAP: 69.09 (unch), CPL: 13.01 (+0.33), CYTR: 2.96 (+0.23), ARNA: 4.55 (+0.02), SWHC: 12.63 (-0.20), EHTH: 10.91 (-0.04), OUTR: 68.39 (+2.22)
Unilife (UNIS) is in Overbought Territory: What's Next?
Unilife's (UNIS) CEO Alan Shortall on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Feb 09, 7:58PM CST
UNIS: 4.32 (+0.06)
Unilife reports 2Q loss
Automated Insights - Mon Feb 09, 5:01PM CST
YORK, Pa. (AP) _ Unilife Corp. (UNIS) on Monday reported a loss of $19.4 million in its fiscal second quarter.
UNIS: 4.32 (+0.06)
Unilife (UNIS) Q2 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Feb 09, 3:25PM CST
UNIS: 4.32 (+0.06)
Unilife Corporation beats by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 3:13PM CST
UNIS: 4.32 (+0.06)
Unilife Corporation Announces Financial Results For Fiscal Year 2015 Second Quarter
PR Newswire - Mon Feb 09, 3:05PM CST
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended December 31, 2014 ("the second quarter of Fiscal Year 2015", "2Q FY15" or "Current Quarter" . UNIS: 4.32 (+0.06)
Unilife to Participate in the 2015 Leerink Global Healthcare Conference
PR Newswire - Fri Feb 06, 9:08AM CST
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS), today announced that its Chairman and CEO, Alan Shortall will participate in a fireside chat at the Leerink Global Healthcare Conference at 1:50 p.m. EST on Thursday, February 12, 2015. The conference will be held at The Waldorf Astoria Hotel in New York City, New York. UNIS: 4.32 (+0.06)
Unilife Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares
PR Newswire - Wed Feb 04, 8:25AM CST
Unilife Corporation ("Unilife"
(NASDAQ: UNIS, ASX: UNS), a leading developer and supplier of injectable drug delivery systems, today announced the closing of its previously announced public offering in the United States of common stock. Prior to the closing, the underwriters exercised in full their option to purchase an additional 1,650,000 shares of common stock. As a result, Unilife issued a total of 12,650,000 shares in the offering at a public price of $3.75 per share. UNIS: 4.32 (+0.06)
Unilife Corporation To Announce Financial Results For Second Quarter Fiscal 2015 On Monday, February 9, 2015
PR Newswire - Mon Feb 02, 7:00AM CST
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the second quarter fiscal 2015 ended December 31, 2014 after market trading ends on Monday, February 9, 2015. UNIS: 4.32 (+0.06)
Unilife (UNIS) Stock Lower Today After Pricing Public Offering
at The Street - Fri Jan 30, 9:51AM CST
Shares of Unilife (UNIS) are down today on heavy trading volume after the company announced a public offering of stock at a price of $3.75 per share.
UNIS: 4.32 (+0.06)
Unilife initiates equity offering
Seeking Alpha - at Seeking Alpha - Fri Jan 30, 9:04AM CST
UNIS: 4.32 (+0.06)
Unilife Corporation Prices Underwritten Offering of Common Stock
PR Newswire - Fri Jan 30, 8:25AM CST
Unilife Corporation ("Unilife"
(NASDAQ: UNIS, ASX: UNS), a leading developer and supplier of injectable drug delivery systems, today announced the pricing of an underwritten public offering in the United States of 11,000,000 shares of its common stock to the public at a price of $3.75 per share. The net proceeds from the offering to Unilife are expected to be $38,792,500, after deducting underwriting discounts and commissions and estimated offering expenses payable by Unilife. In addition, Unilife has granted the underwriters an option for a period of 30 days to purchase up to an additional 1,650,000 shares of its common stock. The offering is expected to close on February 4, 2015, subject to customary closing conditions. UNIS: 4.32 (+0.06)
Unilife Corporation Announces Public Offering of Common Stock
PR Newswire - Thu Jan 29, 6:20PM CST
Unilife Corporation ("Unilife"
(NASDAQ: UNIS, ASX: UNS), a leading developer and supplier of injectable drug delivery systems, today announced it intends to offer and sell, subject to market conditions, shares of its common stock (which will be issued in the form of CHESS Depositary Interests to Australian investors) in an underwritten public offering in the United States and a private placement in Australia (together the "Offering" . Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the proposed Offering. Unilife expects to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the shares of common stock sold in the Offering. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the final size or terms (including price) of the Offering. UNIS: 4.32 (+0.06)
Unilife: Ready For Phase 2 Of A Huge Move
RightEdge Analytics - Seeking Alpha - Thu Jan 29, 10:44AM CST
Update: This article is to update on the recent announcements and runup in share price since the first article that we published on Unilife (NASDAQ: UNIS ) on September 19, 2014 . Since this article UNIS has increased in value by about 70%. This is...
UNIS: 4.32 (+0.06), JPM: 59.67 (+0.10), INCY: 75.94 (+0.28), ABBV: 58.05 (+1.00), SNY: 49.42 (+0.82)
Can the Uptrend Continue for Unilife (UNIS)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 7:37AM CST
Can the Uptrend Continue for Unilife (UNIS)?
UNIS: 4.32 (+0.06)
Health Care Supplies Stocks Technical Review - Cerus, Unilife, DENTSPLY Intl., Alere, and Align Technology
PR Newswire - Thu Jan 22, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Cerus Corporation (NASDAQ: CERS), Unilife Corporation (NASDAQ: UNIS), DENTSPLY International Inc. (NASDAQ: XRAY), Alere Inc. (NYSE: ALR), and Align Technology Inc. (NASDAQ: ALGN). Free research report on Cerus can be accessed at http://get.Investor-Edge.com/pdf/?c=Cerus&...amp;s=CERS. On Wednesday, January 21, 2015, the NASDAQ Composite ended at 4,667.42, up 0.27%, the Dow Jones Industrial Average advanced 0.22%, to finish the day at 17,554.28, and the S&P 500 closed at 2,032.12, up 0.47%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 814.90, up 0.11%, with the index also advancing 10.82% in the previous three months. Register for your complimentary reports at the links given below.
CERS: 5.53 (+0.08), ALGN: 56.90 (-0.34), UNIS: 4.32 (+0.06), ALR: 43.40 (-0.40), XRAY: 52.74 (+0.32)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 8:16AM CST
BCS: 15.77 (+0.12), ANV: 0.97 (-0.03), FRO: 2.96 (+0.07), BAK: 9.02 (+0.03), UNIS: 4.32 (+0.06), EXPR: 14.61 (+0.33), ASPS: 22.32 (+0.09), ISR: 1.34 (-0.06), AU: 12.33 (+0.36), MHR: 2.62 (+0.11), SAP: 69.09 (unch), CPL: 13.01 (+0.33), CYTR: 2.96 (+0.23), ARNA: 4.55 (+0.02), SWHC: 12.63 (-0.20), EHTH: 10.91 (-0.04), OUTR: 68.39 (+2.22)
Unilife (UNIS) is in Overbought Territory: What's Next?
